M K Proteins Ltd
MKPL NSE
M K Proteins Ltd
FMCGNSE: MKPL BSE: 543919 FMCG Products
Key Fundamentals
MicrocapFMCG ProductsFMCGMarket Cap
₹158 Cr
Volatility
Moderate
P/E Ratio
23.28
EBITDA
₹11.42 Cr
Return on Equity
12.09%
Debt to Equity
0.48
Book Value
₹2.03
52W High
₹8.85
52W Low
₹3.56
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view M K Proteins Ltd insights
29 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 4.24% over past five years.
- Company has a low return on equity of 13.5% over last 3 years.
- Company might be capitalizing the interest cost
Growth Rate
Revenue Growth
42.76% ↘
Net Income Growth
-18.10% ↗
Cash Flow Change
-149.75% ↘
ROE
-34.15% ↘
ROCE
-33.94% ↘
EBITDA Margin (Avg.)
-38.05% ↘
Quarterly Results
| Mar 2017 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.59 | 76.2 | 13.64 | 68.86 | 86.87 | 57.33 | 33.69 | 39.48 | 137 | 115 | 32.43 | 89.56 | 146 |
| Expenses | 51.69 | 72.21 | 13 | 65.3 | 78.44 | 53.59 | 31.46 | 37.69 | 133 | 109 | 31.39 | 87.19 | 143 |
| Operating Profit | 1.9 | 3.99 | 0.64 | 3.56 | 8.43 | 3.74 | 2.23 | 1.79 | 4.65 | 5.51 | 1.04 | 2.37 | 2.5 |
| OPM % | 3.55% | 5.24% | 4.69% | 5.17% | 9.7% | 6.52% | 6.62% | 4.53% | 3.39% | 4.79% | 3.21% | 2.65% | 1.71% |
| Other Income | 0.01 | 0 | 0.03 | 0.01 | 0.41 | 0 | 0.21 | 0.25 | 0.02 | 0 | 0.12 | 0.02 | 0.12 |
| Interest | 0.69 | 0.52 | 0.04 | 0.11 | 0.4 | 0.33 | 0.03 | 0.07 | 0.67 | 0.7 | 0.06 | 0.3 | 0.79 |
| Depreciation | 0.3 | 0.12 | 0.12 | 0.12 | 0.18 | 0.07 | 0.07 | 0.11 | 0.09 | 0.1 | 0.11 | 0.12 | 0.11 |
| PBT | 0.92 | 3.35 | 0.51 | 3.34 | 8.26 | 3.34 | 2.34 | 1.86 | 3.91 | 4.71 | 0.99 | 1.97 | 1.72 |
| Tax % | 36.96% | 25.67% | 21.57% | 25.75% | 29.42% | 25.45% | 25.21% | 25.81% | 28.64% | 25.27% | 25.25% | 26.9% | 33.72% |
| Net Profit | 0.57 | 2.49 | 0.41 | 2.48 | 5.83 | 2.48 | 1.74 | 1.38 | 2.8 | 3.51 | 0.75 | 1.43 | 1.14 |
| EPS in Rs | 0.02 | 0.07 | 0.01 | 0.07 | 0.16 | 0.07 | 0.05 | 0.04 | 0.07 | 0.09 | 0.02 | 0.04 | 0.03 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 123 | 145 | 165 | 172 | 157 | 194 | 311 | 256 | 315 | 245 | 268 | 383 |
| Expenses | 119 | 141 | 160 | 166 | 152 | 189 | 295 | 240 | 298 | 229 | 255 | 371 |
| Operating Profit | 4 | 4 | 5 | 6 | 5 | 5 | 16 | 16 | 17 | 17 | 13 | 11 |
| OPM % | 3.4% | 2.9% | 3% | 3.2% | 3.2% | 2.5% | 5% | 6% | 5% | 7% | 4.7% | 3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| PBT | 1 | 1 | 2 | 2 | 2 | 2 | 14 | 14 | 15 | 15 | 11 | 9 |
| Tax % | 32% | 31% | 35% | 35% | 28% | 26% | 27% | 27% | 27% | 28% | 27% | 27% |
| Net Profit | 1 | 1 | 1 | 1 | 2 | 2 | 10 | 10 | 11 | 11 | 8 | 7 |
| EPS in Rs | 1.4 | 1.2 | 0.04 | 0.04 | 0.04 | 0.05 | 0.28 | 0.27 | 0.29 | 0.3 | 0.22 | 0.18 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.68 | 0.68 | 3 | 4 | 4 | 4 | 4 | 4 | 13 | 38 | 38 | 38 |
| Reserves | 2 | 3 | 2 | 11 | 13 | 15 | 25 | 35 | 37 | 24 | 32 | 39 |
| Borrowings | 20 | 26 | 31 | 33 | 26 | 31 | 25 | 37 | 46 | 20 | 39 | 37 |
| Other Liabilities | 13 | 10 | 12 | 8 | 4 | 7 | 13 | 10 | 8 | 15 | 22 | 18 |
| Total Liabilities | 35 | 39 | 47 | 56 | 47 | 57 | 67 | 86 | 103 | 96 | 131 | 131 |
| Fixed Assets | 6 | 7 | 7 | 6 | 4 | 3 | 2 | 3 | 3 | 3 | 4 | 5 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 29 | 32 | 40 | 50 | 43 | 53 | 65 | 83 | 100 | 88 | 120 | 119 |
| Total Assets | 35 | 39 | 47 | 56 | 47 | 57 | 67 | 86 | 103 | 96 | 131 | 131 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 11 | -4 | -4 | -12 | 6 | -4 | 6 | -10 | -6 | 32 | -16 | 5 |
| Investing | 0 | -2 | -1 | 0 | 0 | 0 | 0 | -2 | 0 | -6 | -1 | -2 |
| Financing | -10 | 6 | 5 | 12 | -7 | 4 | -5 | 12 | 6 | -27 | 18 | -3 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 10 | -6 | -5 | -12 | 6 | -4 | 5 | -12 | -6 | 27 | -18 | 4 |
| CFO/OP | 267 | -92 | -65 | -202 | 150 | -77 | 44 | -39 | -6 | 216 | -95 | 70 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16 | 27 | 10 | 39 | 25 | 18 | 24 | 42 | 19 | 5 | 2 | 2 |
| Inventory Days | 70 | 57 | 83 | 69 | 75 | 79 | 48 | 80 | 91 | 134 | 170 | 114 |
| Days Payable | 39 | 22 | 23 | 12 | 6 | 8 | 10 | 8 | 6 | 19 | 29 | 5 |
| Cash Conversion Cycle | 47 | 62 | 70 | 97 | 94 | 89 | 62 | 114 | 104 | 120 | 142 | 110 |
| Working Capital Days | 11 | 9 | 20 | 44 | 32 | 36 | 36 | 55 | 57 | 77 | 81 | 62 |
| ROCE % | 14% | 13% | 12% | 11% | 8% | 8% | 29% | 23% | 20% | 19% | 13% | 10% |
Documents
1
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was Rs 36.19 crore as of 31 March 2026. 30 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was Rs 36.19 crore as of 31 March 2026.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was Rs 36.19 crore as of 31 March 2026. 30 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was Rs 36.19 crore as of 31 March 2026.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Depositories and Participants) Regulation, 2018, we are submitting herewith copy of Certificate issued by M/s Big Share Services Private Limited for the quarter ended March … 10 Apr - Depositories and Participants) Regulation, 2018, we are submitting herewith copy of Certificate issued by M/s Big Share Services Private Limited for the quarter ended March …
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Jan - Depositories and Participants) Regulation, 2018, please find attached herewith copy of Certificate issued by M/s Big Share Services Private Limited for the Quarter ended 31st … 14 Jan - Depositories and Participants) Regulation, 2018, please find attached herewith copy of Certificate issued by M/s Big Share Services Private Limited for the Quarter ended 31st …
Frequently Asked Questions about M K Proteins Ltd
What does M K Proteins Ltd do?
Incorporated in 2012, M K Proteins Ltd is engaged in manufacturing, trading, and production of Edible Oils[1]
Where is M K Proteins Ltd (MKPL) listed?
M K Proteins Ltd is listed on the Indian stock exchanges. It is listed on NSE: MKPL and BSE: 543919. You can view its live share price, financials, and ratios on Tapetide.
Which sector does M K Proteins Ltd belong to?
M K Proteins Ltd operates in the FMCG sector within the FMCG Products industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of M K Proteins Ltd?
M K Proteins Ltd has a market capitalisation of approximately ₹157.66 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of M K Proteins Ltd?
The Price-to-Earnings (PE) ratio of M K Proteins Ltd is 23.28. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of M K Proteins Ltd?
Over the past 52 weeks, M K Proteins Ltd has traded between a low of ₹3.56 and a high of ₹8.85. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of M K Proteins Ltd?
M K Proteins Ltd has a Return on Equity (ROE) of 12.09%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research M K Proteins Ltd on Tapetide?
On Tapetide, you can view M K Proteins Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2012, M K Proteins Ltd is engaged in manufacturing, trading, and production of Edible Oils[1]
Listed 2023-06-13
Face Value ₹ 1
Issued Size 37,53,72,000